Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of CAD 289.55 billion. The enterprise value is 324.77 billion.
Market Cap | 289.55B |
Enterprise Value | 324.77B |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | -0.71% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 12.94 and the forward PE ratio is 9.07.
PE Ratio | 12.94 |
Forward PE | 9.07 |
PS Ratio | 3.34 |
PB Ratio | 4.39 |
P/TBV Ratio | 19.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 14.51 |
EV / Sales | 3.72 |
EV / EBITDA | 8.10 |
EV / EBIT | 9.67 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.72 |
Debt / EBITDA | 1.19 |
Debt / FCF | n/a |
Interest Coverage | 19.27 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 18.59% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 1.17M |
Profits Per Employee | 302,371 |
Employee Count | 75,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 3.74 billion in taxes.
Income Tax | 3.74B |
Effective Tax Rate | 14.32% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 18.37 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 50.60 |
Average Volume (20 Days) | 9,044 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck & Co. had revenue of CAD 86.76 billion and earned 22.38 billion in profits. Earnings per share was 8.84.
Revenue | 86.76B |
Gross Profit | 67.14B |
Operating Income | 33.40B |
Pretax Income | 26.14B |
Net Income | 22.38B |
EBITDA | 39.37B |
EBIT | 33.40B |
Earnings Per Share (EPS) | 8.84 |
Balance Sheet
The company has 12.59 billion in cash and 47.52 billion in debt, giving a net cash position of -34.94 billion.
Cash & Cash Equivalents | 12.59B |
Total Debt | 47.52B |
Net Cash | -34.94B |
Net Cash Per Share | n/a |
Equity (Book Value) | 66.01B |
Book Value Per Share | 26.20 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 77.38%, with operating and profit margins of 38.49% and 25.79%.
Gross Margin | 77.38% |
Operating Margin | 38.49% |
Pretax Margin | 30.12% |
Profit Margin | 25.79% |
EBITDA Margin | 45.37% |
EBIT Margin | 38.49% |
FCF Margin | n/a |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.77% |
Shareholder Yield | n/a |
Earnings Yield | 7.73% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |